These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 17728540)

  • 21. Tex, a putative transcriptional accessory factor, is involved in pathogen fitness in Streptococcus pneumoniae.
    He X; Thornton J; Carmicle-Davis S; McDaniel LS
    Microb Pathog; 2006 Dec; 41(6):199-206. PubMed ID: 16997528
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pyruvate oxidase of Streptococcus pneumoniae contributes to pneumolysin release.
    Bryant JC; Dabbs RC; Oswalt KL; Brown LR; Rosch JW; Seo KS; Donaldson JR; McDaniel LS; Thornton JA
    BMC Microbiol; 2016 Nov; 16(1):271. PubMed ID: 27829373
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Reduced virulence of a defined pneumolysin-negative mutant of Streptococcus pneumoniae.
    Berry AM; Yother J; Briles DE; Hansman D; Paton JC
    Infect Immun; 1989 Jul; 57(7):2037-42. PubMed ID: 2731982
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of decreased BCAA synthesis through disruption of ilvC gene on the virulence of Streptococcus pneumoniae.
    Kim GL; Lee S; Luong TT; Nguyen CT; Park SS; Pyo S; Rhee DK
    Arch Pharm Res; 2017 Aug; 40(8):921-932. PubMed ID: 28735462
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pneumolysin in pneumococcal adherence and colonization.
    Rubins JB; Paddock AH; Charboneau D; Berry AM; Paton JC; Janoff EN
    Microb Pathog; 1998 Dec; 25(6):337-42. PubMed ID: 9895272
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Protection against bacteremic pneumococcal infection by antibody to pneumolysin.
    Musher DM; Phan HM; Baughn RE
    J Infect Dis; 2001 Mar; 183(5):827-30. PubMed ID: 11181163
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pneumolysin is a key factor in misidentification of macrolide-resistant Streptococcus pneumoniae and is a putative virulence factor of S. mitis and other streptococci.
    Neeleman C; Klaassen CH; Klomberg DM; de Valk HA; Mouton JW
    J Clin Microbiol; 2004 Sep; 42(9):4355-7. PubMed ID: 15365043
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Streptococcus pneumoniae: the role of apoptosis in host defense and pathogenesis.
    Marriott HM; Dockrell DH
    Int J Biochem Cell Biol; 2006; 38(11):1848-54. PubMed ID: 16844403
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of subinhibitory concentrations of antibiotics on mutation frequency in Streptococcus pneumoniae.
    Henderson-Begg SK; Livermore DM; Hall LM
    J Antimicrob Chemother; 2006 May; 57(5):849-54. PubMed ID: 16531433
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Presence of nonhemolytic pneumolysin in serotypes of Streptococcus pneumoniae associated with disease outbreaks.
    Jefferies JM; Johnston CH; Kirkham LA; Cowan GJ; Ross KS; Smith A; Clarke SC; Brueggemann AB; George RC; Pichon B; Pluschke G; Pfluger V; Mitchell TJ
    J Infect Dis; 2007 Sep; 196(6):936-44. PubMed ID: 17703426
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Research progress in pneumolysin].
    Rui W; Nie K; Fang R
    Wei Sheng Wu Xue Bao; 2017 Mar; 57(3):333-40. PubMed ID: 29756432
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Effects of subinhibitory concentrations of antibiotics on the virulence of group A hemolytic Streptococci].
    Michel J; Ferne M; Rotenberg M
    Pathol Biol (Paris); 1983 Jun; 31(6):528-32. PubMed ID: 6348663
    [TBL] [Abstract][Full Text] [Related]  

  • 33. β-sitosterol interacts with pneumolysin to prevent Streptococcus pneumoniae infection.
    Li H; Zhao X; Wang J; Dong Y; Meng S; Li R; Niu X; Deng X
    Sci Rep; 2015 Dec; 5():17668. PubMed ID: 26631364
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Neutrophil transendothelial migration in vitro to Streptococcus pneumoniae is pneumolysin dependent.
    Moreland JG; Bailey G
    Am J Physiol Lung Cell Mol Physiol; 2006 May; 290(5):L833-40. PubMed ID: 16339781
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Construction and immunological characterization of a novel nontoxic protective pneumolysin mutant for use in future pneumococcal vaccines.
    Kirkham LA; Kerr AR; Douce GR; Paterson GK; Dilts DA; Liu DF; Mitchell TJ
    Infect Immun; 2006 Jan; 74(1):586-93. PubMed ID: 16369015
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Oligomerisation of pneumolysin on cholesterol crystals: similarities to the behaviour of polyene antibiotics.
    Sonnen AF; Rowe AJ; Andrew PW; Gilbert RJ
    Toxicon; 2008 Jun; 51(8):1554-9. PubMed ID: 18501941
    [TBL] [Abstract][Full Text] [Related]  

  • 37. In vitro interactions of LytA, the major pneumococcal autolysin, with two bacteriophage lytic enzymes (Cpl-1 and Pal), cefotaxime and moxifloxacin against antibiotic-susceptible and -resistant Streptococcus pneumoniae strains.
    Rodríguez-Cerrato V; García P; Del Prado G; García E; Gracia M; Huelves L; Ponte C; López R; Soriano F
    J Antimicrob Chemother; 2007 Nov; 60(5):1159-62. PubMed ID: 17827138
    [TBL] [Abstract][Full Text] [Related]  

  • 38. THP-1 monocytes up-regulate intercellular adhesion molecule 1 in response to pneumolysin from Streptococcus pneumoniae.
    Thornton J; McDaniel LS
    Infect Immun; 2005 Oct; 73(10):6493-8. PubMed ID: 16177322
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Differences in virulence for mice among Streptococcus pneumoniae strains of capsular types 2, 3, 4, 5, and 6 are not attributable to differences in pneumolysin production.
    Benton KA; Paton JC; Briles DE
    Infect Immun; 1997 Apr; 65(4):1237-44. PubMed ID: 9119457
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Contribution of the ATP-dependent protease ClpCP to the autolysis and virulence of Streptococcus pneumoniae.
    Ibrahim YM; Kerr AR; Silva NA; Mitchell TJ
    Infect Immun; 2005 Feb; 73(2):730-40. PubMed ID: 15664911
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.